A Study to Evaluate the Safety and Efficacy of SH-1028 in Locally Advanced or Metastatic NSCLC

Clinical trial NCT03823807 · UNKNOWN

Trial details

NCT number: NCT03823807
Sponsor: Nanjing Sanhome Pharmaceutical, Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2019-03-01
Primary completion: 2020-12-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.